MedTech Emerging Minds with Atul Deshpande | CEO of IMMEDIATE Therapeutics

In this edition of MedTech Emerging Minds, we sit down with Atul Deshpande, CEO of Immediate Therapeutics, to explore how a deceptively simple drug combination—glucose, potassium, and insulin—is transforming cardiac emergency care. Atul shares his journey from neuroscience research to biotech leadership, the challenges of scaling therapies globally, and how IMMEDIATE’s breakthrough therapy, IMT-358, may reshape the future of heart attack treatment.

🔬 Learn how a 3-ingredient IV could halve cardiac arrest deaths and reduce infarct size by 80%, all before the patient arrives at the hospital.

💡 If you're in life sciences, biotech, investing, or just fascinated by innovation in healthcare—this is a must-watch.

🔗 Connect with Atul or Learn More:
🌐 Website: https://immediatetherapeutics.com
🔗 LinkedIn:   / atuldeshpande  

⏱️ Timestamps:
00:00 – Intro: Meet Atul Deshpande, CEO of Immediate Therapeutics
01:23 – Atul’s career path: From neuroscience to biotech executive
05:44 – The Dupixent launch story and global success
08:05 – Transitioning from Big Pharma to Biotech: Key skill differences
10:45 – The founding story of Immediate Therapeutics
13:12 – What happens during a heart attack—and what’s broken in current care
16:23 – How IMT-358 works: Glucose, Potassium, and Insulin synergy
19:50 – Phase II trial results: 50% reduction in cardiac arrest and death
21:47 – 80% reduction in infarct size—what that means for recovery and quality of life
24:00 – Regulatory milestones: Breakthrough designation & SPA explained
27:40 – Fast-tracked Phase III trial and the FDA’s unprecedented support
30:03 – Future expansion: High-risk surgery and broader cardiometabolic applications
32:17 – Lessons in biotech startup leadership: Build a team, follow the money
35:42 – Going global: Launch strategy and regulatory insights across markets
39:16 – The BLA strategy and how Immediate built market exclusivity
43:25 – How to invest or connect with Immediate Therapeutics
45:04 – Closing thoughts: The global impact of changing the heart attack standard of care

🧠 MedTech Emerging Minds brings together innovators, founders, and thought leaders shaping the future of health.

👍 Like, comment, and subscribe for more insights into the intersection of technology, medicine, and leadership.

#MedTech #Cardiology #BiotechInnovation #HeartHealth #Startups #HealthcareInnovation #EmergencyCare #FDAapproval #Entrepreneurship #ImmediateTherapeutics